Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Selective Embolization of Thyroid Arteries (SETA) as an Adjunctive or Definitive Treatment for Different Thyroid Disorders

NCT06537141 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT06537141
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06537141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Selective Embolization of Thyroid Arteries (SETA) as an Adjunctive or Definitive Treatment for Different Thyroid Disorders
Lead sponsor
Assiut University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 10, 2024
Completion date
July 30, 2026
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

goiter diffuse, goiter malignant, goiter, nodular, graves disease